- Home
- NKTX vs WBX Comparison
NKTX vs WBX Comparison
Compare NKTX & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- WBX
- Stock Information
- Founded
- NKTX 2015
- WBX 2015
- Country
- NKTX United States
- WBX Spain
- Employees
- NKTX N/A
- WBX N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- WBX Industrial Specialties
- Sector
- NKTX Health Care
- WBX Consumer Discretionary
- Exchange
- NKTX Nasdaq
- WBX Nasdaq
- Market Cap
- NKTX 123.5M
- WBX 102.7M
- IPO Year
- NKTX 2020
- WBX N/A
- Fundamental
- Price
- NKTX $1.77
- WBX $0.30
- Analyst Decision
- NKTX Strong Buy
- WBX Buy
- Analyst Count
- NKTX 6
- WBX 3
- Target Price
- NKTX $14.40
- WBX $0.72
- AVG Volume (30 Days)
- NKTX 422.2K
- WBX 605.9K
- Earning Date
- NKTX 08-12-2025
- WBX 07-31-2025
- Dividend Yield
- NKTX N/A
- WBX N/A
- EPS Growth
- NKTX N/A
- WBX N/A
- EPS
- NKTX N/A
- WBX N/A
- Revenue
- NKTX N/A
- WBX $171,352,140.00
- Revenue This Year
- NKTX N/A
- WBX N/A
- Revenue Next Year
- NKTX N/A
- WBX $44.10
- P/E Ratio
- NKTX N/A
- WBX N/A
- Revenue Growth
- NKTX N/A
- WBX 3.75
- 52 Week Low
- NKTX $1.31
- WBX $0.23
- 52 Week High
- NKTX $8.23
- WBX $1.64
- Technical
- Relative Strength Index (RSI)
- NKTX 46.34
- WBX 42.70
- Support Level
- NKTX $1.76
- WBX $0.31
- Resistance Level
- NKTX $2.08
- WBX $0.38
- Average True Range (ATR)
- NKTX 0.11
- WBX 0.04
- MACD
- NKTX -0.00
- WBX -0.00
- Stochastic Oscillator
- NKTX 25.00
- WBX 57.36
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.